Patents Assigned to Coda Biotherapeutics, Inc.
  • Compositions and methods for neurological diseases
    Patent number: 10538571
    Abstract: Compositions and methods are provided for modulating the activity of cells using engineered receptors, polynucleotide encoded engineered receptors, and gene therapy vectors comprising polynucleotides encoding engineered receptors. These compositions and methods find particular use in modulating the activity of neurons, for example in the treatment of disease or in the study of neuronal circuits.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: January 21, 2020
    Assignee: Coda Biotherapeutics, Inc.
    Inventors: Kenneth P. Greenberg, Orion Keifer, Jr., Stefanie Makinson, Anthony Lau